Anthony Petrone analyst MIZUHO

Currently out of the existing stock ratings of Anthony Petrone, 175 are a BUY (81.02%), 38 are a HOLD (17.59%), 3 are a SELL (1.39%).

Anthony Petrone

Work Performance Price Targets & Ratings Chart

Analyst Anthony Petrone, currently employed at MIZUHO, carries an average stock price target met ratio of 59.55% that have a potential upside of 33.04% achieved within 214 days. Previously, Anthony Petrone worked at JEFFERIES.

Anthony Petrone’s has documented 444 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on HOLX, Hologic at 05-Nov-2024.

Wall Street Analyst Anthony Petrone

Analyst best performing recommendations are on VRAY (VIEWRAY).
The best stock recommendation documented was for ISRG (INTUITIVE SURGICAL) at 1/24/2023. The price target of $245 was fulfilled within 1 day with a profit of $12.98 (5.03%) receiving and performance score of 50.31.

Average potential price target upside

ATRS Antares Pharma COO The Cooper Companies . Common Stock EW Edwards Lifesciences Corp HAE Haemonetics MNK Mallinckrodt plc RMD ResMed TARS Tarsus Pharmaceuticals  VAR Varian Medical Systems VREX Varex Imaging Corp ALC Alcon AG GKOS Glaukos Corp HOLX Hologic LMAT LeMaitre Vascular LNTH Lantheus Holdings ZBH Zimmer Biomet Holdings LIVN LivaNova PLC ABMD ABIOMED ABT Abbott Laboratories ADMA ADMA Biologics ESTA Establishment Labs Holdings MDT Medtronic PLC STAA STAAR Surgical Company ISRG Intuitive Surgical INSP Inspire Medical Systems NVRO Nevro Corp TFX Teleflex orporated VRAY ViewRay MDXG MiMedx Group AXNX Axonics Modulation Technologies BSX Boston Scientific Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$6

$0.41 (7.33%)

$6

2 years 7 months 9 days ago
(14-Apr-2022)

0/3 (0%)

$0.44 (7.91%)

Hold

$5.6

$0.01 (0.18%)

$6

2 years 7 months 9 days ago
(14-Apr-2022)

2/4 (50%)

$0.04 (0.72%)

374

Hold

2 years 7 months 9 days ago
(14-Apr-2022)

7/8 (87.5%)

$1.2 (31.58%)

367

Hold

$7

2 years 7 months 10 days ago
(13-Apr-2022)

0/1 (0%)

$2.85 (68.67%)

Buy

$8

$2.41 (43.11%)

$7

6 years 17 days ago
(06-Nov-2018)

2/4 (50%)

$4.39 (121.61%)

584

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Anthony Petrone is most bullish on?

Potential upside of $58.29 has been obtained for TFX (TELEFLEX ORPORATED)

Which stock is Anthony Petrone is most reserved on?

Potential downside of -$7.18 has been obtained for ADMA (ADMA BIOLOGICS)

What Year was the first public recommendation made by Anthony Petrone?

On 2010

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?